These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31776548)

  • 1. Paradoxical association between blood modular interferon signatures and quality of life in patients with systemic lupus erythematosus.
    Seguier J; Jouve E; Bobot M; Whalen E; Dussol B; Gentile S; Burtey S; Halfon P; Retornaz F; Chaussabel D; Chiche L; Jourde-Chiche N
    Rheumatology (Oxford); 2020 Aug; 59(8):1975-1983. PubMed ID: 31776548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.
    Chiche L; Jourde-Chiche N; Whalen E; Presnell S; Gersuk V; Dang K; Anguiano E; Quinn C; Burtey S; Berland Y; Kaplanski G; Harle JR; Pascual V; Chaussabel D
    Arthritis Rheumatol; 2014 Jun; 66(6):1583-95. PubMed ID: 24644022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
    Chaigne B; Chizzolini C; Perneger T; Trendelenburg M; Huynh-Do U; Dayer E; Stoll T; von Kempis J; Ribi C;
    BMC Immunol; 2017 Mar; 18(1):17. PubMed ID: 28351341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Aerobic Capacity and Quality of Life in Physically Inactive Patients With Systemic Lupus Erythematosus With Mild or Inactive Disease.
    Pinto AJ; Miyake CN; Benatti FB; Silva CA; Sallum AM; Borba E; de Sá-Pinto AL; Bonfá E; Gualano B
    Arthritis Care Res (Hoboken); 2016 Dec; 68(12):1780-1786. PubMed ID: 27058995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of self-reported health-related quality of life in systemic lupus erythematosus.
    Kiani AN; Strand V; Fang H; Jaranilla J; Petri M
    Rheumatology (Oxford); 2013 Sep; 52(9):1651-7. PubMed ID: 23681396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
    Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
    Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus.
    Jiang HZ; Lin ZG; Li HJ; -Du Q; -Tian W; Wang SY; Guan SQ; Mei YF
    Clin Rheumatol; 2018 Jan; 37(1):151-160. PubMed ID: 29168029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?
    Jolly M
    J Rheumatol; 2005 Sep; 32(9):1706-8. PubMed ID: 16142864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial.
    Jolly M; Annapureddy N; Arnaud L; Devilliers H
    Lupus; 2019 Dec; 28(14):1628-1639. PubMed ID: 31674267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus.
    Azizoddin DR; Weinberg S; Gandhi N; Arora S; Block JA; Sequeira W; Jolly M
    Lupus; 2018 Apr; 27(5):728-737. PubMed ID: 29087259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of SLE on health-related quality of life assessed with SF-36: a systemic review and meta-analysis.
    Gu M; Cheng Q; Wang X; Yuan F; Sam NB; Pan H; Li B; Ye D
    Lupus; 2019 Mar; 28(3):371-382. PubMed ID: 30813871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quality of life in Chinese patients with systemic lupus erythematosus is associated with disease activity and psychiatric disorders: a path analysis.
    Shen B; Feng G; Tang W; Huang X; Yan H; He Y; Chen W; Da Z; Liu H; Gu Z
    Clin Exp Rheumatol; 2014; 32(1):101-7. PubMed ID: 24029416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus.
    Katz P; Wan GJ; Daly P; Topf L; Connolly-Strong E; Bostic R; Reed ML
    Qual Life Res; 2020 Dec; 29(12):3251-3261. PubMed ID: 32683643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-cultural validation of Lupus Impact Tracker in five European clinical practice settings.
    Schneider M; Mosca M; Pego-Reigosa JM; Gunnarsson I; Maurel F; Garofano A; Perna A; Porcasi R; Devilliers H
    Rheumatology (Oxford); 2017 May; 56(5):818-828. PubMed ID: 28204765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of the SF-36 in Japanese patients with systemic lupus erythematosus and its associations with disease activity and damage: a two-consecutive year prospective study.
    Baba S; Katsumata Y; Okamoto Y; Kawaguchi Y; Hanaoka M; Kawasumi H; Yamanaka H
    Lupus; 2018 Mar; 27(3):407-416. PubMed ID: 28795653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study.
    Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
    Arthritis Res Ther; 2020 Jan; 22(1):8. PubMed ID: 31924267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired sexual function in women with systemic lupus erythematosus: a cross-sectional study.
    García Morales M; Callejas Rubio JI; Peralta-Ramírez MI; Henares Romero LJ; Ríos Fernández R; Camps García MT; Navarrete Navarrete N; Ortego Centeno N
    Lupus; 2013 Sep; 22(10):987-95. PubMed ID: 23963430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus.
    Benitha R; Tikly M
    Clin Rheumatol; 2007 Jan; 26(1):24-9. PubMed ID: 16538390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of social support on health-related quality of life in patients with systemic lupus erythematosus.
    Zheng Y; Ye DQ; Pan HF; Li WX; Li LH; Li J; Li XP; Xu JH
    Clin Rheumatol; 2009 Mar; 28(3):265-9. PubMed ID: 19002545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.